Angiogenesis in synchronous and metachronous colorectal liver metastases: the liver as a permissive soil

Ann Surg. 2012 Jan;255(1):86-94. doi: 10.1097/SLA.0b013e318238346a.

Abstract

Objective: Resection of a primary colorectal carcinoma (CRC) can be accompanied by rapid outgrowth of liver metastases, suggesting a role for angiogenesis. The aim of this study is to investigate whether the presence of a primary CRC is associated with changes in angiogenic status and proliferation/apoptotic rate in synchronous liver metastases and/or adjacent liver parenchyma.

Methods: Gene expression and localization of CD31, HIF-1α, members of the vascular endothelial growth factor (VEGF) and Angiopoietin (Ang) system were studied using qRT-PCR and immunohistochemistry in colorectal liver metastases and nontumorous-adjacent liver parenchyma. Proliferation and apoptotic rate were quantified. Three groups of patients were included: (1) simultaneous resection of synchronous liver metastases and primary tumor (SS-group), (2) resection of synchronous liver metastases 3 to 12 months after resection of the primary tumor [late synchronous (LS-group)], and (3) resection of metachronous metastases >14 months after resection of the primary tumor (M-group).

Results: In all 3 groups a higher expression of the angiogenic factors was encountered in adjacent liver parenchyma as compared to the metastases. VEGFR-2 gene expression was abundant in adjacent liver parenchyma in all 3 groups. VEGF-A and VEGFR-1 were prominent in adjacent parenchyma in the SS-group. The SS-group showed the highest Ang-2/Ang-1 ratio both in the metastases and the adjacent liver. This was accompanied by a high turnover of tumor cells.

Conclusion: In the presence of the primary tumor, the liver parenchyma adjacent to the synchronous liver metastases provides an angiogenic prosperous environment for metastatic tumor growth.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Apoptosis / genetics
  • Cell Proliferation
  • Colorectal Neoplasms / blood supply*
  • Colorectal Neoplasms / pathology
  • Colorectal Neoplasms / surgery
  • Disease Progression
  • Female
  • Gene Expression Regulation, Neoplastic / genetics
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / genetics
  • Liver / blood supply
  • Liver / pathology
  • Liver Neoplasms / blood supply*
  • Liver Neoplasms / secondary*
  • Liver Neoplasms / surgery
  • Male
  • Membrane Proteins / genetics
  • Middle Aged
  • Neoplasms, Multiple Primary / blood supply*
  • Neoplasms, Multiple Primary / genetics
  • Neoplasms, Multiple Primary / pathology
  • Neoplasms, Multiple Primary / secondary*
  • Neoplasms, Multiple Primary / surgery
  • Neoplasms, Second Primary / blood supply*
  • Neoplasms, Second Primary / genetics
  • Neoplasms, Second Primary / pathology
  • Neoplasms, Second Primary / secondary*
  • Neoplasms, Second Primary / surgery
  • Neovascularization, Pathologic / genetics
  • Neovascularization, Pathologic / pathology*
  • Platelet Endothelial Cell Adhesion Molecule-1 / genetics
  • Prognosis
  • Real-Time Polymerase Chain Reaction
  • Ribonuclease, Pancreatic / genetics
  • Vascular Endothelial Growth Factor A / genetics
  • Vascular Endothelial Growth Factor Receptor-2 / genetics

Substances

  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Membrane Proteins
  • PIGF protein, human
  • Platelet Endothelial Cell Adhesion Molecule-1
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factor Receptor-2
  • angiogenin
  • Ribonuclease, Pancreatic